A trial to investigate the effect of oral semaglutide on the pharmacokinetics of furosemide and rosuvastatin in healthy subjects

被引：0
|
作者：
Baekdal, T. A. [1 ]
Albayaty, M. [2 ]
Manigandan, E. [3 ]
Anderson, T. W. [1 ]
Skibsted, S. [1 ]
机构：
[1] Novo Nordisk AS, Soborg, Denmark
[2] Parexel, London, England
[3] Novo Nordisk, Bangalore, Karnataka, India
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
714
引用
收藏
页码：S346 / S347
页数：2
相关论文
共 50 条
  • [41] A Study Investigating the Effect of Omeprazole on the Pharmacokinetics of Oral Semaglutide
    Adrian, Charlotte L.
    Breitschaft, Astrid
    Baekdal, Tine A.
    Olesen, Martin
    Sondergaard, Flemming L.
    DIABETES, 2017, 66 : A320 - A320
  • [42] Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects
    Csonka, Denes
    Bruderer, Shirin
    Schultz, Armin
    Soergel, Marianne
    Stepanova, Radka
    Sabattini, Giancarlo
    Perez-Ruixo, Juan Jose
    CLINICAL DRUG INVESTIGATION, 2019, 39 (12) : 1223 - 1232
  • [43] Effect of oral semaglutide on the pharmacokinetics of thyroxine after dosing of levothyroxine and the influence of co-administered tablets on the pharmacokinetics of oral semaglutide in healthy subjects: an open-label, one-sequence crossover, single-center, multiple-dose, two-part trial
    Hauge, Camilla
    Breitschaft, Astrid
    Hartoft-Nielsen, Marie-Louise
    Jensen, Simon
    Baekdal, Tine A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (09) : 1139 - 1148
  • [44] Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects
    Dénes Csonka
    Shirin Bruderer
    Armin Schultz
    Marianne Soergel
    Radka Stepanova
    Giancarlo Sabattini
    Juan Jose Perez-Ruixo
    Clinical Drug Investigation, 2019, 39 : 1223 - 1232
  • [45] EFFECT OF CYP2C19 POLYMORPHISM ON THE PHARMACOKINETICS OF ROSUVASTATIN IN HEALTHY TAIWANESE SUBJECTS.
    Wang, Y.
    Wang, T.
    Finkelman, R. D.
    Jou, H.
    Azumaya, C. T.
    Mosqueda-Garcia, R.
    Birmingham, B. K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S22 - S22
  • [46] A phase 1, randomized, double-blind, placebo-controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects
    Xie, Panpan
    Abildlund, Morten T.
    Baekdal, Tine A.
    He, Xuemei
    Lyauk, Yassine K.
    Patted, Usha Rani H.
    Ning, Zu
    Shi, Aixin
    DIABETES OBESITY & METABOLISM, 2024, 26 (08): : 3068 - 3077
  • [47] Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes
    Charlotte Granhall
    Morten Donsmark
    Thalia M. Blicher
    Georg Golor
    Flemming L. Søndergaard
    Mette Thomsen
    Tine A. Bækdal
    Clinical Pharmacokinetics, 2019, 58 : 781 - 791
  • [48] Effect of Rifampin on the Single-Dose Pharmacokinetics of Oral Cabotegravir in Healthy Subjects
    Ford, S. L.
    Sutton, K.
    Lou, Y.
    Zhang, Z.
    Tenorio, A.
    Trezza, C.
    Patel, P.
    Spreen, W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (10)
  • [49] Absence of food effect on the pharmacokinetics of telbivudine following oral administration in healthy subjects
    Zhou, XJ
    Lloyd, DM
    Chao, GC
    Brown, NA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (03): : 275 - 281
  • [50] Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes
    Granhall, Charlotte
    Donsmark, Morten
    Blicher, Thalia M.
    Golor, Georg
    Sondergaard, Flemming L.
    Thomsen, Mette
    Baekdal, Tine A.
    CLINICAL PHARMACOKINETICS, 2019, 58 (06) : 781 - 791
12345